Company intelligence / Profile preview

ING Pharmaceutical

Sunrise, Florida, United States

Ownership: Private
Development stage: Other

Overview

ING Pharmaceutical provides private label turnkey manufacturing of OTC supplements, nutraceuticals, and vitamins in formats including softgel, capsule, tablet, powder, and gummies. The company emphasizes rapid product development, regulatory and stability expertise, and innovative instant-dissolve tablet formats, but does not develop original investigational drugs or biologic therapeutics.

Therapeutic areas: ImmunologyRheumatologyMetabolic DisordersGastroenterologyOtherWomen's Health
Modalities: Small molecule (nutraceuticals, vitamins, over-the-counter actives)BotanicalsDietary supplementMicrobial therapy
Industry: Food & Nutrition

Partnerships

Not specified (contract manufacturer for brands/retailers)

Beyond the preview

Go deeper on ING Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ING Pharmaceutical.

Explore the full profile